Lung Cancer Considered

LCC in Spanish: ESMO 2026 Highlights

En este episodio en español de Lung Cancer Considered, la Dra. Narjust Florez conversa con la Dra. Ana Velázquez Mañana sobre los principales avances en la investigación del cáncer de pulmón presentados en ESMO 2026 en Madrid. Destacan los resultados de los estudios DeLLphi-305, SAFFRON y Krascendo 1, explorando los avances en el tratamiento del cáncer de pulmón de células pequeñas y las terapias dirigidas para el cáncer de pulmón de células no pequeñas con mutaciones de EGFR y KRAS G12C. La conversación también aborda el estudio MOIO y sus implicaciones para los intervalos de administración de la inmunoterapia, la seguridad de los tratamientos y la práctica clínica.

In this Spanish-language episode of Lung Cancer Considered, host Dr. Narjust Florez welcomes Dr. Ana Velázquez Mañana to discuss key lung cancer research presented at ESMO 2026 in Madrid. They highlight findings from the DeLLphi-305, SAFFRON, and Krascendo 1 trials, exploring advances in small cell lung cancer treatment and targeted therapies for EGFR-mutated and KRAS G12C-mutated non-small cell lung cancer. The conversation also examines the MOIO trial and its implications for immunotherapy dosing intervals, treatment safety, and clinical practice.

In this episode of Lung Cancer Considered, Drs. Jacob Sands, Ferdinandos Skoulidis, and Jarushka Naidoo discuss key research highlights from ESMO 2026, including results from the DeLLphi-305 trial evaluating tarlatamab in extensive-stage small cell lung cancer and the KRAScendo-1 trial investigating divarasib in KRAS G12C-mutated NSCLC. The discussion also explores emerging immunotherapy strategies, including findings from the MOIO and OptiTROP-Lung06 studies, advances in predicting immune-related toxicities, and the potential implications of these developments for clinical practice.

Jaruska Naidoo, MD
Professor of Medical Oncology
Royal College of Surgeons
Consultant, Medical Oncologist at Beaumont Hospital
X: @DrJNaidoo
Instagram: jarushkanaidoo
LinkedIn: https://www.linkedin.com/in/jarushka-naidoo-127a3b97/

Jacob Sands, MD
Assistant Professor of Medicine, Harvard Medical School
Associate Chief, Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
X: @sands_jacob
Instagram: jacobsands
LinkedIn: https://www.linkedin.com/in/jacobsands/

Ferdinandos Skoulidis, MD, PhD
Professor, Department of Thoracic and Head and Neck Medical Oncology
University of Texas MD Anderson Cancer Center

In this Georgian-language episode of Lung Cancer Considered, Dr. Elene Mariamidze is joined by Dr. Mariam Tchiabrishvili and Dr. Lasha Khmaladze for a multidisciplinary discussion of a challenging case of EGFR-mutated non-small cell lung cancer (NSCLC). Through a case-based discussion, they explore molecular testing, treatment strategies, management of brain metastases, and the role of EGFR tyrosine kinase inhibitors (EGFR TKIs), while highlighting evolving treatment options and challenges in accessing care in Georgia.

Guests:

Elene Mariamidze, MD
Clinical Oncologist, Todua Clinic
President of Georgian School of Oncology (GSO)

Mariam Tchiabrishvili, MD
Radiation Oncologist
Todua Clinic
Tbilisi State University

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.

In this episode, host Dr. Nagla Karim moderates a discussion in Arabic about highlights from the conference with Dr. Bashir Abu Aqeel, Dr. Riad Abdel Jalil, Dr. Kamal Al-rabi, Dr. Myriam Saadi, Dr. Ahmed Magdy Rabea, and Dr. Hussein Soudy.

Guests:

Nagla Karim, MD
Professor of Medicine
Director of Thoracic Oncology and Phase I Programs
George Washington University

Riad Abdel Jalil, MD
Thoracic Surgeon
King Hussein Cancer Center

Bashir Abu Aqeel, MD
Medical Oncologist
Augusta Victoria Hospital

Kamal Al-rabi, MD
Medical Oncology
King Hussien Cancer Center

Ahmed Magdy Rabea
Assistant Professor of Medical
National Cancer Institute, Cairo University

Myriam Saadi, MD
Assistant Professor of Medical Oncology, University of Tunis el Manar
Faculty of Medicine of Tunis, Department of Medical Oncology
Abderrahman Mami Hospital

Hussein Soudy, MBBS, PhD
Senior Consultant, Medical Oncology
St. George & Sutherland Hospitals, Sydney

The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.

In this episode, guest host Dr. Kuan Yu Chen moderates a discussion in Mandarin with Dr. Bin-Chi Liao, Dr. Mong-Wei Lin, and Dr. Po-Lan Su, leading lung cancer experts in Taiwan, who share their perspectives on key highlights from the conference.

Guests:
Kuan-Yu Chen, MD, PhD
Clinical Professor and Chief, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine
National Taiwan University Hospital and College of Medicine

Bin-Chi Liao, MD
Department of Medical Oncology
National Taiwan University Cancer Center

Mong-Wei Lin, MD, PhD
Professor of Surgery, National Taiwan University College of Medicine
Chief, Division of Thoracic Surgery
National Taiwan University Hospital

Dr. Po-Lan Su, MD, PhD
Clinical Associate Professor, Department of Internal Medicine
National Chung Kung University Hospital, Taiwan